Skip to Content
Tell us what you think: The PAPAA Forum

The PAPAA Forum: Coronavirus (COVID-19), Dr David Ashton

Sulfasalasine and Covid-19 infection

Sulfasalasine, a disease-modifying antirheumatic drug (DMARD), has a well-established role in the treatment of patients with chronic inflammatory diseases, such a rheumatoid arthritis, inflammatory bowel disease and psoriatic arthritis.  It is often used in patients who are unable to tolerate methotrexate. Sulfasalasine has anti-inflammatory,…

Update to COVID-19 FAQs

COVID-19 remains a serious health risk. You should stay cautious to help protect yourself and others. The latest advice from the UK Government says:

  • Let fresh air in if you meet indoors. Meeting outdoors is safer
  • You must wear a face covering in shops and on all public transport (check local differences)
  • Get tested and self-isolate, if required
Lung disease and psoriasis

Introduction

One of the significant symptoms of Covid-19 is a persistent cough and, in severe cases, shortness of breath.  Whilst this is not the place to discuss the specific features or details of coronavirus infection, it’s a useful moment to review the various lung conditions associated with psoriasis and whether any of the current systemic…

Psoriasis patients more susceptible to COVID-19

As the COVID-19 pandemic has continued, researchers have been able to study individual groups of patients with pre-existing medical conditions – including psoriasis.  One especially important question, is whether patients diagnosed with psoriasis, could be more at risk of infection with COVID-19?  

In a recent (virtual) meeting of the American…

Show More